26.81 USD
↗ 0.97 (3.75%)AT CLOSE (11:59 AM EDT)
Assembly Biosciences, Inc
ASMBNASDAQ • USD
26.76
↘ 0.05 (0.19%)
POST MARKET (AS OF 07:32 PM EDT)
Post Market
AS OF 07:32 PM EDT
26.76
↘ 0.05 (0.19%)
Market: CLOSED
ASMB is currently priced at $26.80. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. ASMB is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$26.12
High?$28.15
Low?$25.36
Prev. Close?$25.84
Volume?312.8K
Avg. Volume?244.2K
VWAP?$27.06
Rel. Volume?1.28x
Bid / Ask
Bid?$23.12 × 100
Ask?$31.92 × 100
Spread?$8.80
Midpoint?$27.52
Valuation & Ratios
Market Cap?512.1M
Shares Out?15.9M
Float?10.9M
Float %?68.4%
P/E Ratio?N/A
P/B Ratio?2.58
EPS?-$0.32
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
Employees
73
Market Cap
512.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2010-12-17
Address
TWO TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
Phone: (833) 409-4583
SOUTH SAN FRANCISCO, CA 94080
Phone: (833) 409-4583
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?96
Momentum?73
Short Sent.?15
Piotroski F-Score?2/9Weak
Altman Z-Score?4.45Safe
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?22.14%Squeeze Risk
Short Interest?2.4M
Days to Cover?6.6
Free Float10.9M
Avg Daily Volume365.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?6.65Strong
Quick Ratio?6.65Strong
Cash Ratio?0.89Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.58CHEAP▾
Peers100
S&P63
P/S?7.20HIGH▾
Peers100
S&P16
P/FCF?N/A▾
EV/EBITDA?-35.8CHEAP▾
S&P97
EV/Sales?6.76HIGH▾
Peers100
S&P22
Returns & Efficiency
ROE?-3.2%WEAK▾
S&P12
ROA?-2.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-39836000
Enterprise Value?$481.0M
Fundamentals ratios updated end of day